Related Experiment Video
Updated: Apr 20, 2026

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.4K
Human vaccines & immunotherapeutics: news
1a Founder and Chairman Emeritus; Vaccinogen, Inc.; Frederick, MD USA.
Human Vaccines & Immunotherapeutics
|November 27, 2014
Summary
Harnessing the immune system for cancer therapy is promising. Early research explored graft-versus-host disease and B-cell responses to soluble antigens, revealing key immune mechanisms.
Area of Science:
- Immunology
- Cancer Therapy
- Transplantation
Background:
- Graft-versus-host (GVH) disease, a consequence of bone marrow transplantation, highlighted the immune system's potential for adverse clinical outcomes.
- The concept of utilizing immunological phenomena for cancer therapy emerged in the late 1960s, despite limited understanding of T-cells.
Purpose of the Study:
- To investigate the early changes in lymphatic tissue germinal centers following soluble antigen stimulation in mice.
- To understand the role of dendritic reticular cells in presenting extracellular soluble antigens.
- To elucidate the B-cell response leading to antibody production.
Main Methods:
- Studied graft-versus-host disease in mice.
- Administered soluble antigens to mice.
- Observed changes in lymphatic tissue germinal centers within 48 hours post-stimulation.
- Examined the localization of antigens on dendritic reticular cells.
Main Results:
- Described post-antigen stimulation changes in lymphatic tissue germinal centers.
- Identified extracellular soluble antigens on dendritic reticular cells.
- Demonstrated that these cells direct B-cell responses.
- Observed rapid proliferation of B-cells into antibody-secreting plasma cells.
Conclusions:
- The study elucidated early events in the humoral immune response, including antigen presentation by dendritic reticular cells.
- These findings provided foundational insights into B-cell activation and antibody production.
- Understanding these mechanisms is crucial for developing immunotherapies, including for cancer.
Keywords:
Active Specific ImmunotherapyAutologous Tumor CellsBacillus Calmette Guerin (BCG)Bladder CancerCancer DiversityCancer Genomic HeterogeneityCancer VaccinesGerminal CentersLymphatic TissueMechanism of Humoral ImmunityOncoVAXTumor AntigensMore Related Videos
Related Concept Videos
Cancer Vaccines
1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Microorganisms in Medicine and Therapeutics
1.5K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.5K
Vaccinations
54.7K
Overview
54.7K
Vaccines
63
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
63
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Vaccine Production
110
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
110

